Fostemsavir Tris
Fostemsavir Tris (BMS-663068 Tris) is an oral prodrug of the active attachment inhibitor BMS-626529. It blocks HIV-1 infection by binding to viral gp120, preventing its attachment to host CD4+ T-cells. This mechanism has been validated in both in vitro antiviral assays and in vivo clinical research for antiretroviral therapy.
Product Specifications
CAS Number
864953-39-9
Product Name Alternative
Field of Research
Infectious Disease & Virology, Pharmacology & Drug Discovery, Protein Biochemistry
Purity
99.45% (May vary between batches)
Solubility
H2O:100 mg/mL (141.92 mM) ; DMSO:125 mg/mL (177.4 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (5.68 mM)
Smiles
O=C (N1CCN (C (C2=CC=CC=C2) =O) CC1) C (C3=CN (COP (O) (O) =O) C4=C3C (OC) =CN=C4N5N=C (C) N=C5) =O.OCC (CO) (N) CO
Molecular Formula
C29H37N8O11P
Molecular Weight
704.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MAP Kinase Kinase 3 (Dual Specificity Mitogen-activated Protein Kinase Kinase 3, Mitogen-activated Protein Kinase Kinase 3, MAP2K3, MAPKK 3, MKK3, MAPK/ERK Kinase 3, MEK 3, MEK3, PRKMK3, Stress-activated Protein Kinase Kinase 2, SAPK Kinase 2, SAPKK2, SAPKK-2, SKK2) (FITC) discontinued
